American Association for the Advancement of Science, Science Translational Medicine, 602(13), 2021
DOI: 10.1126/scitranslmed.abg6128
Full text: Unavailable
Fc effector functions and antibody specificity, rather than IgG or neutralizing titers, may serve as protective correlates for Ebola vaccines.